-
-
Call more information
660-596-2224 -
Author: Richard Novak, MD THE ANESTHESIA CONSULTANT June 2023 Gary Kasparov head to head. Is it feasible that CHATGPT, this decades artificial intelligence wunderkind, can equal or better a physician anesthesiologist? I entered three anesthesia consultations into CHATGPT, one preoperative, one intraoperative, and one postoperative. Is CHATGPT as good as an MD? Let’s look at […]
Read MoreASA Monitor July 2023, Vol. 87, 11. A 10-year-old boy with a complex past medical history notable for neonatal stroke resulting in cortical blindness, tracheo-esophageal fistula that was repaired in infancy, and ASD/VSD repair requiring subsequent pacemaker placement and pacemaker dependence presented for iliac bone graft for correction of an alveolar maxillary cleft defect. Preoperatively, the […]
Read MoreASA Monitor July 2023, Vol. 87, 10. A 45-year-old woman is scheduled to undergo a bilateral mastectomy for metastatic breast cancer. According to a recent study of patients undergoing breast cancer surgery with general anesthesia maintained with propofol or volatile agents, which of the following MOST likely describes overall survival with use of propofol compared to […]
Read MoreAuthors: Kira A. Spencer, Ph.D. et al Anesthesiology July 2023, Vol. 139, 63–76. Background A variety of molecular targets for volatile anesthetics have been suggested, including the anesthetic-sensitive potassium leak channel, TREK-1. Knockout of TREK-1 is reported to render mice resistant to volatile anesthetics, making TREK-1 channels compelling targets for anesthetic action. Spinal cord slices from […]
Read MoreASA Monitor July 2023, Vol. 87, 12–34. Technology Infused tympanostomy tubes for treatment of middle ear infections Middle ear infections are extremely common and affect children especially, with 40% developing recurrent infections that can lead to complications like impaired hearing, speech and language delays, perforations in their eardrums, and life-threatening meningitis. “Tympanostomy tubes” (TTs) are surgically […]
Read MoreAuthor: Paul Pomerantz, FACHE ASA Monitor July 2023, Vol. 87, 1–7. It is daunting to reflect on the fact that I have just a few quarterly columns left. In this one, I will share my observations on the major trends impacting the specialty and the society. In October, I will reflect on the major milestones of […]
Read MoreAuthors: Julia Klein, MD et al ASA Monitor July 2023, Vol. 87, 27–28. The PACU functions as a triage center where decisions are made as to whether the patient is ready for discharge, transfer to the floor, or whether continued ICU-level of care is needed. Although the 2013 ASA Practice Guidelines for Postanesthetic Care include mental […]
Read MoreAuthors: Jennifer J. Yuan, MD, MBA et al ASA Monitor July 2023, Vol. 87, 21. Traditionally, a doctor’s role has been as a patient’s advocate, with a focus on medical care and clinical decision-making. To be an effective clinician, some believe that a physician should be separated from conflicting financial interests, and administrative management should be […]
Read MoreKeya A. Locke, MD, MBA et al ASA Monitor July 2023, Vol. 87, 14–15. “The operating room should be at the disposal of the surgeons 24/7, no questions asked.” “Every day at 3 p.m. it’s like rats scurrying off the deck of the Titanic, and we can’t get any work done.” “1:30 p.m. is the bewitching […]
Read MoreASA Monitor July 2023, Vol. 87, 7. Which of the following immunosuppressive drugs is MOST likely to cause renal dysfunction? □ (A) Tacrolimus □ (B) Mycophenolate mofetil □ (C) Basiliximab Immunosuppressant drugs are used to prevent or treat allograft rejection. Most of these drugs act during the induction phase of the immunological response, reducing lymphocyte proliferation. Some of them […]
Read More